Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2015

Open Access 01-12-2015 | Poster presentation

Audit of high prevalent breast screening recall rates: Torbay Hospital

Authors: Alexander Crowther, Rebecca Green

Published in: Breast Cancer Research | Special Issue 1/2015

Login to get access

Excerpt

The target percentage of women recalled after prevalent round breast screening is <7 % with minimum standards <10 %. Torbay Hospital's prevalent round recall is high at 11.4 %. We plan to assess patterns of recall by category to see if any particular reason for recall could be decreased. …
Metadata
Title
Audit of high prevalent breast screening recall rates: Torbay Hospital
Authors
Alexander Crowther
Rebecca Green
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2015
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3784

Other articles of this Special Issue 1/2015

Breast Cancer Research 1/2015 Go to the issue

Poster presentation

Use of sulphur hexafluoride microbubbles injection to identify the sentinel lymph node in breast cancer patients: initial experience in a UK breast unit

Poster presentation

Breast biopsy in patients on anti-coagulants: is new guidance needed?

Poster presentation

Outcome of ultrasound of the mammographically normal contralateral breast in patients recalled to the screening assessment clinic

Poster presentation

Evaluation of the use of microbubbles in the ultrasound assessment of the axilla in breast cancer patients

Poster presentation

Breast cancer in women under 35 years

Poster presentation

Prospective study looking at CT staging for metastases in early breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits